MELASCREEN
Anti-Dark Spot Concentrate
MELASCREEN treatment is the first dermatological solution highly concentrated in active ingredients to effectively depigment all types of brown spots (melasma, chloasma, post-inflammatory hyperpigmentation), for all phototypes.
It contains more than 15% dermatological active ingredients that act on the factors responsible for the formation of brown spots, including vascularization. This concentrated treatment offers selective depigmentation even on the most difficult to correct brown spots while preserving the skin's natural pigmentation.
-
For whom?WomenPregnant womanBreastfeeding
-
Price
-
TextureLightweight, non-sticky, non-comedogenic.
Patient relations
-
Application tips
Twice a day on the face, neck and/or neckline for at least 1 month.
In addition to specific daily sun protection.
Ingredients
Active ingredients:
Called HMC, methylated derivative of the flavonic compound "hesperidin " that can be found in several fruits (citrus).
Active recognized for its depigmenting, anti-inflammatory and antioxidant properties, dicarboxylic acid naturally present in wheat, rye and barley. It is often used to correct the first signs of ageing.
Active belonging to the family of alpha-hydroxy acids (AHA). Glycolic acid has keratolytic and moisturizing properties on the stratum corneum.
Formula details:
Click on an ingredient type to highlight it in the list
Clinical results and publications
Efficacy results
Intensity of hyperpigmentation from 2 weeks (2).
Of subjects who rated a brightening effect at 2 months (investigator rating) (3).
Reduction in size and intensity of hyperpigmentation at 1 month (4).
More even and uniform complexion at 1 month (4).
Tolerance results
Good skin tolerance in all skin types (1).
Excellent ocular tolerance (1).
Links to clinical results
View all clinical resultsLegal Notice
Tolerance and efficacy study in 55 adult women of phototypes II to V with melasma, facial lentigo or post-inflammatory hyperpigmentation related to acne. 2 applications per day on the face, neck and décolletage.
(1) Skin and eye tolerance rated by investigators.
(2) Significant difference in the ITA angle between the hyperpigmented spot and the adjacent area (intensity of staining measured by spectrometry) of -20% at 2 weeks.
(3) Efficacy perceived by the investigator: % of subjects for whom the product was rated as effective at 2 months.
(4) % subject satisfaction after 1 month.
Frontal macrophotographs
M0
M+3
Profile macrophotographs
M0
M+3
Discover the range
Contact us
Would you like to meet a sales representative?
Our medical sales representatives come to your workplace to answer all your questions about our brands and products.
The product concerned may not be available in your country. Please contact your medical sales representative for further information.
Have you noticed any side effects?
The safety and well-being of your patients is our priority. If you notice an unlisted adverse reaction to one of our products, please contact us without delay. We look forward to hearing from you!
Our commitments
Made in France
Product manufactured in our factories in France.
Conscious Care
Pierre Fabre Laboratories brands, including Ducray Dermatological Laboratories, have joined forces and collectively created Conscious Care: a dermo-cosmetic of the future that acts conscientiously towards its entire ecosystem.
Supporting associations
Ducray Dermatological Laboratories support 14 patient associations around the world, with the objective of sharing information on pathologies to improve their management.
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.